115 related articles for article (PubMed ID: 38211518)
1. Quantification and clinical validation of the selective MET kinase inhibitor DO-2 and its metabolites DO-5 and M3 in human plasma.
Sikkema BJ; Mathijssen RHJ; Robbrecht DGJ; Perera TPS; Koolen SLW; de Bruijn P
J Pharm Biomed Anal; 2024 Mar; 240():115962. PubMed ID: 38211518
[TBL] [Abstract][Full Text] [Related]
2. Validated bioanalytical method for the quantification of RGB-286638, a novel multi-targeted protein kinase inhibitor, in human plasma and urine by liquid chromatography/tandem triple-quadrupole mass spectrometry.
de Bruijn P; Moghaddam-Helmantel IM; de Jonge MJ; Meyer T; Lam MH; Verweij J; Wiemer EA; Loos WJ
J Pharm Biomed Anal; 2009 Dec; 50(5):977-82. PubMed ID: 19628352
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of osimertinib, alectinib and lorlatinib in human cerebrospinal fluid by UPLC-MS/MS.
de Leeuw SP; de Bruijn P; Koolen SLW; Dingemans AC; Mathijssen RHJ; Veerman GDM
J Pharm Biomed Anal; 2023 Feb; 225():115233. PubMed ID: 36638566
[TBL] [Abstract][Full Text] [Related]
4. Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC-MS/MS for therapeutic drug monitoring.
Zhang M; Liu X; Chen Z; Jiang S; Wang L; Tao M; Miao L
J Pharm Biomed Anal; 2022 Mar; 211():114562. PubMed ID: 35124453
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method to quantify antiretroviral drug concentrations in human plasma for therapeutic monitoring.
West RE; Oberly PJ; Riddler SA; Nolin TD; Devanathan AS
J Pharm Biomed Anal; 2024 Mar; 240():115932. PubMed ID: 38198884
[TBL] [Abstract][Full Text] [Related]
6. Determination of meloxicam in human plasma by ultra-high-performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study.
Zhang S; Chen S; Song Y; Xin Y; Cui Y; Qin F
Biomed Chromatogr; 2022 Aug; 36(8):e5395. PubMed ID: 35514216
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous Determination of Orelabrutinib, Zanubrutinib, Ibrutinib and Its Active Metabolite in Human Plasma Using LC-MS/MS.
Sun LN; Zhao Y; Qian ZY; Chen XL; Ma H; Guo YJ; Shen H; Wang YQ
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770870
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous detection of a panel of nine sedatives and metabolites in plasma from critically ill pediatric patients via UPLC-MS/MS.
Birabaharan J; West RE; Nolin TD; Traube C; Bell MJ; Empey PE
J Pharm Biomed Anal; 2022 Sep; 218():114853. PubMed ID: 35659658
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous and enantiospecific quantification of primaquine and carboxyprimaquine in human plasma using liquid chromatography-tandem mass spectrometry.
Hanpithakpong W; Day NPJ; White NJ; Tarning J
Malar J; 2022 Jun; 21(1):169. PubMed ID: 35659684
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a newly developed high performance liquid chromatography method with diode array detection to a liquid chromatography tandem mass spectrometry method for the quantification of cabozantinib, dabrafenib, nilotinib and osimertinib in human serum - Application to therapeutic drug monitoring.
Aghai-Trommeschlaeger F; Zimmermann S; Gesierich A; Kalogirou C; Goebeler ME; Jung P; Pelzer T; Kurlbaum M; Klinker H; Isberner N; Scherf-Clavel O
Clin Biochem; 2022; 105-106():35-43. PubMed ID: 35483452
[TBL] [Abstract][Full Text] [Related]
11. LC-MS/MS methods for determination of venetoclax in human plasma and cerebrospinal fluid.
Yang YL; Qian ZY; Zhao Y; Chen XL; Huang QY; Guo YJ; Sun LN; Wang YQ
Biomed Chromatogr; 2023 Dec; 37(12):e5738. PubMed ID: 37724003
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
[TBL] [Abstract][Full Text] [Related]
13. Rat Pharmacokinetics and In Vitro Metabolite Identification of KM-819, a Parkinson's Disease Candidate, Using LC-MS/MS and LC-HRMS.
Choi HI; Kim T; Kim JW; Lee GJ; Choi J; Chae YJ; Kim E; Koo TS
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474516
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of an UPLC-MS/MS method for the determination of irinotecan (CPT-11), SN-38 and SN-38 glucuronide in human plasma and peritoneal tumor tissue from patients with peritoneal carcinomatosis.
Gasthuys E; van Ovost J; Vande Casteele S; Cosyns S; Ceelen W; Van Bocxlaer J; Vermeulen A
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb; 1233():123980. PubMed ID: 38215697
[TBL] [Abstract][Full Text] [Related]
15. Determination of Osimertinib, Aumolertinib, and Furmonertinib in Human Plasma for Therapeutic Drug Monitoring by UPLC-MS/MS.
Li Y; Meng L; Ma Y; Li Y; Xing X; Guo C; Dong Z
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889345
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous quantification of fentanyl, sufentanil, cefazolin, doxapram and keto-doxapram in plasma using liquid chromatography-tandem mass spectrometry.
Flint RB; Bahmany S; van der Nagel BCH; Koch BCP
Biomed Chromatogr; 2018 Oct; 32(10):e4290. PubMed ID: 29768657
[TBL] [Abstract][Full Text] [Related]
17. High-Throughput Ultra Performance Liquid Chromatography-Tandem Mass Spectrometry Method Validation for the Estimation of Atorvastatin and Active Metabolites in Human Plasma.
Agrawal N; Mittal A
Assay Drug Dev Technol; 2023 Apr; 21(3):110-125. PubMed ID: 37036476
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of anacetrapib, stable-isotope labeled-anacetrapib (microdose), and four metabolites in human plasma using liquid chromatography tandem mass spectrometry.
Chavez-Eng CM; Lutz RW; Li H; Goykhman D; Bateman KP; Woolf E
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1011():204-14. PubMed ID: 26773885
[TBL] [Abstract][Full Text] [Related]
19. Development and clinical validation of a simple and fast UPLC-ESI-MS/MS method for simultaneous quantification of nine kinase inhibitors and two antiandrogen drugs in human plasma: Interest for their therapeutic drug monitoring.
Llopis B; Robidou P; Tissot N; Pinna B; Gougis P; Aubart FC; Campedel L; Abbar B; Weil DR; Uzunov M; Gligorov J; Salem JE; Funck-Brentano C; Zahr N
J Pharm Biomed Anal; 2021 Apr; 197():113968. PubMed ID: 33618135
[TBL] [Abstract][Full Text] [Related]
20. Ultra-performance liquid chromatography-tandem mass spectrometry quantitative profiling of tryptophan metabolites in human plasma and its application to clinical study.
Chen Y; Chen H; Shi G; Yang M; Zheng F; Zheng Z; Zhang S; Zhong S
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Oct; 1128():121745. PubMed ID: 31586884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
